SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-033319
Filing Date
2017-02-07
Accepted
2017-02-07 16:38:32
Documents
5
Period of Report
2017-02-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d339006d8k.htm 8-K 13141
2 EX-99.1 d339006dex991.htm EX-99.1 13328
3 GRAPHIC g339006gale1.jpg GRAPHIC 12963
4 GRAPHIC g339006gale2.jpg GRAPHIC 10373
5 GRAPHIC g339006gale3.jpg GRAPHIC 45220
  Complete submission text file 0001193125-17-033319.txt   122511
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 17579526
SIC: 2834 Pharmaceutical Preparations